M
Mineralys Therapeutics, Inc. (MLYS)
NMS – Real vaqt narxi. Valyuta: USD
29.26
-0.47 (-1.58%)
Yopilishda: May 12, 2026, 4:00 PM EDT
29.26
0.00 (0.00%)
Bozordan keyin: May 12, 2026, 5:42 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NMS – Real vaqt narxi. Valyuta: USD
29.26
-0.47 (-1.58%)
Yopilishda: May 12, 2026, 4:00 PM EDT
29.26
0.00 (0.00%)
Bozordan keyin: May 12, 2026, 5:42 PM EDT
Mineralys Therapeutics, Inc., bir biofarmatsevtika kompaniyasi, Qo'shma Shtatlarda aldesteronning tartibsizligi sababli yuzaga keladigan kasalliklarni davolash uchun dori-darmonlarni ishlab chiqadi. U gipertenziya, surunkali buyrak kasalligi va obstruktsion uyqu apnesi kabi aldesteronning tartibsizligi ta'sir qiladigan yurak-buyrak kasalliklarini davolash uchun patentlangan, og'iz orqali yuboriladigan, juda selektiv aldesteron sintaza ingibitori bo'lgan lorundrostatni ishlab chiqmoqda. Kompaniya ilgari Catalys SC1, Inc. nomi bilan tanilgan va 2020 yil may oyida Mineralys Therapeutics, Inc. nomini o'zgartirgan. Mineralys Therapeutics, Inc. 2019 yilda ro'yxatga olingan va shtab-kvartirasi Radnor, Pensilvaniyada joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Brian Taylor Slingsby M.D., M.P.H., Ph.D. | Founder & Executive Director |
| Dr. David M. Rodman M.D. | Chief Medical Officer |
| Dr. Robert McKean Ph.D. | Senior Vice President of CMC |
| Mr. Adam Scott Levy | CFO & Secretary |
| Mr. Eric J. Warren R.Ph. | Chief Commercial Officer |
| Mr. Jeffrey A. Munsie J.D. | Chief Legal Officer |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-05-06 | 10-Q | mlys-20260331.htm |
| 2026-04-10 | ARS | mineralystherapeutics_2026.pdf |
| 2026-04-08 | DEFA14A | mlys-additionalproxymateri.htm |
| 2026-03-12 | 10-K | mlys-20251231.htm |
| 2026-03-09 | 8-K | mlys-20260306.htm |
| 2026-02-13 | S-8 | a2026forms-8.htm |
| 2026-01-06 | 8-K | mlys-20260106.htm |
| 2025-11-10 | 10-Q | mlys-20250930.htm |
| 2025-09-02 | S-3MEF | mlys-formsx3mef.htm |
| 2025-08-12 | 8-K | mlys-20250812.htm |
| Mr. Jon Congleton | President, CEO & Director |
| Ms. Danielle Mahoney | Senior Vice President of Quality Assurance |
| Ms. Jessica Ibbitson | Executive Vice President of Operations |
| Ms. Tiffany Ellen Burt | Senior Vice President of Medical Affairs |